Highlights
NASDAQ: AXSM       Axsome Thera
Last Price Today's Change   Day's Range   Trading Volume
79.42   +2.68 (3.49%)  76.27 - 79.88  402,900

Overview

 
Avg Volume (4 weeks):632,480
4 Weeks Range:74.11 - 89.26
4 Weeks Price Volatility (%):
35.05%
52 Weeks Range:13.64 - 109.94
52 Weeks Price Volatility (%):
68.31%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Axsome Therapeutics Inc is a United States-based healthcare service provider. As a pre-clinical therapeutics developer, the company attends primarily to central nervous system disorders such as Alzheimer's. Its product portfolio consists of novel drugs like the AXS-02 (disodium zoledronate tetrahydrate), which is an oral, non-opioid therapeutic for chronic pain and the AXS-05, which is a fixed-dose combination of dextromethorphan and bupropion. The AXS-02 addresses pain in over three conditions, such as complex regional pain syndrome, knee osteoarthritis and chronic low back pain. The AXS-05 on the other hand, treats resistant depression and agitation in patients with Alzheimer's disease. Both the products have passed the preclinical, Phase 1 and Phase 2 stages of development.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5841  2426  488  170 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 RIGL 4.125+1.965 
 SQQQ 6.42-0.14 
 NIO 14.09+0.25 
 LK 1.38+1.38 
 VXRT 16.97+4.85 
 WFC 24.25-1.16 
 BOXL 1.94+0.37 
 F 6.36+0.30 
 XLF 23.68+0.12 
 SPY 318.92+4.08 
Partners & Brokers